| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | GW 441756 | GDSC1000 | pan-cancer | AAC | -0.0096 | 0.8 |
| mRNA | KU 0060648 | CTRPv2 | pan-cancer | AAC | 0.0092 | 0.8 |
| mRNA | Bexarotene | FIMM | pan-cancer | AAC | 0.04 | 0.8 |
| mRNA | BRD-A71883111 | CTRPv2 | pan-cancer | AAC | 0.0095 | 0.8 |
| mRNA | apicidin | CTRPv2 | pan-cancer | AAC | 0.0079 | 0.8 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | 0.0092 | 0.8 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | 0.0095 | 0.8 |
| mRNA | BIRB 0796 | CTRPv2 | pan-cancer | AAC | -0.0096 | 0.8 |
| mRNA | HG-5-88-01 | GDSC1000 | pan-cancer | AAC | 0.012 | 0.8 |